| Literature DB >> 29160382 |
Maria Teresa Ruiz Tsukazan1,2, Álvaro Vigo2, Vinícius Duval da Silva3, Carlos Henrique Barrios4, Jayme de Oliveira Rios1, José Antônio de Figueiredo Pinto1.
Abstract
OBJECTIVE: To describe the trends in tumor histology, gender and age among patients with non-small cell lung cancer (NSCLC) treated with lung resection. The histology of lung cancer has changed in developed countries, and there is still little information available on the topic for developing countries.Entities:
Mesh:
Year: 2017 PMID: 29160382 PMCID: PMC5790654 DOI: 10.1590/S1806-37562016000000339
Source DB: PubMed Journal: J Bras Pneumol ISSN: 1806-3713 Impact factor: 2.624
Clinical characteristics of the patients, in the sample as a whole and by gender.a
| Characteristic | Total | Male | Female | p |
|---|---|---|---|---|
| (N = 1,030) | (n = 665) | (n = 365) | ||
| Histological type | < 0.001 | |||
| Squamous cell carcinoma | 418 (40.6) | 312 (46.9) | 106 (29) | |
| Adenocarcinoma | 458 (44.5) | 269 (40.4) | 189 (51.8) | |
| Carcinoid tumor | 36 (3.5) | 15 (2.3) | 21 (5.8) | |
| Large-cell carcinoma | 32 (3.1) | 19 (2.9) | 13 (3.6) | |
| Mucoepidermoid carcinoma | 7 (0.7) | 3 (0.4) | 4 (1.1) | |
| Adenosquamous carcinoma | 49 (4.8) | 31 (4.7) | 18 (4.9) | |
| Undifferentiated NSCLC | 11 (1.0) | 7 (1.0) | 4 (1.1) | |
| Other | 19 (1.8) | 9 (1.4) | 10 (2.7) | |
| Degree of tumor invasion | < 0.001 | |||
| T1a | 144 (14) | 73 (11) | 71 (19.5) | |
| T1b | 109 (10.6) | 71 (10.7) | 38 (10.4) | |
| T2a | 340 (33) | 191 (28.7) | 149 (40.8) | |
| T2b | 152 (14.8) | 107 (16.1) | 45 (12.3) | |
| T3 | 237 (23.0) | 183 (27.5) | 54 (14.8) | |
| T4 | 48 (4.6) | 40 (6.0) | 8 (2.2) | |
| Lymph node involvement | < 0.023 | |||
| N0 | 654 (63.5) | 410 (61.6) | 244 (66.9) | |
| N1 | 197 (19.1) | 145 (21.8) | 52 (14.2) | |
| N2 | 174 (16.9) | 107 (16.1) | 67 (18.4) | |
| N3 | 5 (0.5) | 3 (0.5) | 2 (0.5) | |
| Stage | < 0.001 | |||
| IA | 188 (18.3) | 106 (15.9) | 82 (22.5) | |
| IB | 225 (21.8) | 124 (18.7) | 101 (27.7) | |
| IIA | 147 (14.3) | 102 (15.3) | 45 (12.3) | |
| IIB | 175 (17.0) | 131 (19.7) | 44 (12.0) | |
| IIIA | 237 (23.0) | 157 (23.6) | 80 (21.9) | |
| IIIB | 21 (2.0) | 16 (2.4) | 5 (1.4) | |
| IV | 37 (3.6) | 29 (4.4) | 8 (2.2) |
NSCLC: non-small cell lung cancer. aValues expressed as n (%).
Figure 1Adjusted mean age at surgery, by gender.
Clinical characteristics of the patients, by period.a
| Characteristic | Period | p | ||
|---|---|---|---|---|
| 1986-1995 | 1996-2005 | 2006-2015 | ||
| (n = 244) | (n = 291) | (n = 495) | ||
| Histological type | < 0.001 | |||
| Squamous cell carcinoma | 121 (49.6) | 125 (43.0) | 172 (34.8) | |
| Adenocarcinoma | 93 (38.1) | 120 (41.2) | 245 (49.5) | |
| Carcinoid tumor | 9 (3.7) | 2 (0.7) | 25 (5.0) | |
| Large-cell carcinoma | 6 (2.5) | 12 (4.1) | 14 (2.8) | |
| Other NSCLC | 15 (6.1) | 32 (11.0) | 39 (7.9) | |
| Type of surgery | ||||
| Lobectomy | 177 (72.5) | 229 (78.7) | 414 (83.6) | < 0.001 |
| Segmentectomy | 0 | 0 | 13 (2.6) | |
| Bilobectomy | 19 (7.8) | 16 (5.5) | 20 (4.1) | |
| Pneumonectomy | 48 (19.7) | 46 (15.8) | 48 (9.7) | |
| Stage | < 0.001 | |||
| IA | 33 (13.5) | 44 (15.1) | 111 (22.4) | |
| IB | 57 (23.4) | 46 (15.8) | 122 (24.7) | |
| IIA | 38 (15.6) | 39 (13.4) | 70 (14.1) | |
| IIB | 51 (20.9) | 56 (19.2) | 68 (13.8) | |
| IIIA | 55 (22.5) | 84 (28.9) | 98 (19.8) | |
| IIIB | 8 (3.3) | 8 (2.8) | 5 (1.0) | |
| IV | 2 (0.8) | 14 (5.0) | 21 (4.2) | |
NSCLC: non-small cell lung cancer. aValues expressed as n (%).
Figure 2Histological type, by period and gender. W: women; M: men.
Características clínicas dos pacientes, na amostra geral e por gênero.a
| Características | Total | Homens | Mulheres | p |
|---|---|---|---|---|
| (N = 1.030) | (n = 665) | (n = 365) | ||
| Tipo histológico | < 0,001 | |||
| Carcinoma de células escamosas | 418 (40,6) | 312 (46,9) | 106 (29,0) | |
| Adenocarcinoma | 458 (44,5) | 269 (40,4) | 189 (51,8) | |
| Tumor carcinoide | 36 (3,5) | 15 (2,3) | 21 (5,8) | |
| Carcinoma de grandes células | 32 (3,1) | 19 (2,9) | 13 (3,6) | |
| Carcinoma mucoepidermoide | 7 (0,7) | 3 (0,4) | 4 (1,1) | |
| Carcinoma adenoescamoso | 49 (4,8) | 31 (4,7) | 18 (4,9) | |
| CPCNP indiferenciado | 11 (1,0) | 7 (1,0) | 4 (1,1) | |
| Outros | 19 (1,8) | 9 (1,4) | 10 (2,7) | |
| Grau de invasão tumoral | < 0,001 | |||
| T1a | 144 (14) | 73 (11) | 71 (19,5) | |
| T1b | 109 (10,6) | 71 (10,7) | 38 (10,4) | |
| T2a | 340 (33) | 191 (28,7) | 149 (40,8) | |
| T2b | 152 (14,8) | 107 (16,1) | 45 (12,3) | |
| T3 | 237 (23,0) | 183 (27,5) | 54 (14,8) | |
| T4 | 48 (4,6) | 40 (6,0) | 8 (2,2) | |
| Comprometimento linfonodal | < 0,023 | |||
| N0 | 654 (63,5) | 410 (61,6) | 244 (66,9) | |
| N1 | 197 (19,1) | 145 (21,8) | 52 (14,2) | |
| N2 | 174 (16,9) | 107 (16,1) | 67 (18,4) | |
| N3 | 5 (0,5) | 3 (0,5) | 2 (0,5) | |
| Estádio | < 0,001 | |||
| IA | 188 (18,3) | 106 (15,9) | 82 (22,5) | |
| IB | 225 (21,8) | 124 (18,7) | 101 (27,7) | |
| IIA | 147 (14,3) | 102 (15,3) | 45 (12,3) | |
| IIB | 175 (17,0) | 131 (19,7) | 44 (12,0) | |
| IIIA | 237 (23,0) | 157 (23,6) | 80 (21,9) | |
| IIIB | 21 (2,0) | 16 (2,4) | 5 (1,4) | |
| IV | 37 (3,6) | 29 (4,4) | 8 (2,2) |
CPCNP: câncer de pulmão de células não pequenas. aValores expressos em n (%).
Figura 1Média ajustada da idade à cirurgia, por gênero.
Características clínicas dos pacientes, por período.a
| Características | Período | p | ||
|---|---|---|---|---|
| 1986-1995 | 1996-2005 | 2006-2015 | ||
| (n = 244) | (n = 291) | (n = 495) | ||
| Tipo histológico | < 0,001 | |||
| Carcinoma de células escamosas | 121 (49,6) | 125 (43,0) | 172 (34,8) | |
| Adenocarcinoma | 93 (38,1) | 120 (41,2) | 245 (49,5) | |
| Tumor carcinoide | 9 (3,7) | 2 (0,7) | 25 (5,0) | |
| Carcinoma de grandes células | 6 (2,5) | 12 (4,1) | 14 (2,8) | |
| Outros CPCNP | 15 (6,1) | 32 (11,0) | 39 (7,9) | |
| Tipo de cirurgia | ||||
| Lobectomia | 177 (72,5) | 229 (78,7) | 414 (83,6) | < 0,001 |
| Segmentectomia | 0 | 0 | 13 (2,6) | |
| Bilobectomia | 19 (7,8) | 16 (5,5) | 20 (4,1) | |
| Pneumonectomia | 48 (19,7) | 46 (15,8) | 48 (9,7) | |
| Estádio | < 0,001 | |||
| IA | 33 (13,5) | 44 (15,1) | 111 (22,4) | |
| IB | 57 (23,4) | 46 (15,8) | 122 (24,7) | |
| IIA | 38 (15,6) | 39 (13,4) | 70 (14,1) | |
| IIB | 51 (20,9) | 56 (19,2) | 68 (13,8) | |
| IIIA | 55 (22,5) | 84 (28,9) | 98 (19,8) | |
| IIIB | 8 (3,3) | 8 (2,8) | 5 (1,0) | |
| IV | 2 (0,8) | 14 (5,0) | 21 (4,2) | |
CPCNP: câncer de pulmão de células não pequenas. aValores expressos em n (%).
Figura 2Tipo histológico, por período e gênero. M: mulheres; H: homens.